Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 2, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, November 1, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
M. Auster Maintained (UTHR) at Sell with Decreased Target to $103 on, Nov 1st, 2018
M. Auster of Credit Suisse, Maintained "United Therapeutics Corporation" (UTHR) at Sell with Decreased Target from $106 to $103 on, Nov 1st, 2018.
M. has made no other calls on UTHR in the last 4 months.
There is 1 other peer that has a rating on UTHR. Out of the 1 peers that are also analyzing UTHR, 0 agree with M.'s Rating of Hold.
This is the rating of the analyst that currently disagrees with M.
- Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $253 on, Thursday, August 2nd, 2018
